Ram I. Mahato
Ram I. Mahato is a prominent figure in the field of pharmaceutical sciences and drug delivery. He is known for his significant contributions to the development of biodegradable polymers, gene delivery systems, and nanomedicine.
Early Life and Education[edit | edit source]
Ram I. Mahato was born in Nepal. He completed his undergraduate studies in pharmacy at the Institute of Medicine, Tribhuvan University. He then pursued his M.S. in pharmaceutical sciences from the University of Tokyo. Mahato earned his Ph.D. in pharmaceutics from the University of Utah.
Career[edit | edit source]
Mahato began his academic career as a postdoctoral fellow at the University of Southern California. He later joined the faculty at the University of Tennessee Health Science Center where he served as a professor of pharmaceutical sciences. Currently, he is a professor at the University of Nebraska Medical Center.
Research Contributions[edit | edit source]
Mahato's research focuses on the development of biodegradable polymers for drug delivery, gene therapy, and nanomedicine. His work has led to the creation of novel drug delivery systems that improve the efficacy and safety of therapeutic agents. He has published numerous articles in peer-reviewed journals and holds several patents in the field of pharmaceutical sciences.
Biodegradable Polymers[edit | edit source]
Mahato has developed various biodegradable polymers that are used in drug delivery systems. These polymers are designed to degrade within the body, releasing the drug in a controlled manner.
Gene Delivery Systems[edit | edit source]
Mahato's work in gene delivery involves the use of non-viral vectors to deliver therapeutic genes to target cells. His research aims to improve the efficiency and specificity of gene delivery, reducing the risk of adverse effects.
Nanomedicine[edit | edit source]
In the field of nanomedicine, Mahato has developed nanoparticles for the targeted delivery of drugs. These nanoparticles can be engineered to deliver drugs to specific tissues or cells, enhancing the therapeutic effect while minimizing side effects.
Awards and Honors[edit | edit source]
Mahato has received several awards for his contributions to pharmaceutical sciences, including the AAPS Fellow award and the Controlled Release Society Fellow award. He is also a member of various professional organizations, such as the American Association of Pharmaceutical Scientists and the Controlled Release Society.
Publications[edit | edit source]
Mahato has authored and co-authored numerous research articles, book chapters, and books on drug delivery and biodegradable polymers. His publications are widely cited in the field of pharmaceutical sciences.
Personal Life[edit | edit source]
Mahato resides in Omaha, Nebraska with his family. He is actively involved in community service and mentoring young scientists.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
